Junyi Ye
China Pharmaceutical University(CN)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Cancer Genomics and Diagnostics, Epigenetics and DNA Methylation, RNA modifications and cancer, Lung Cancer Research Studies
Most-Cited Works
- → Whole-exome and targeted gene sequencing of gallbladder carcinoma identifies recurrent mutations in the ErbB pathway(2014)467 cited
- → Lung Adenocarcinoma Harboring EGFR T790M and In Trans C797S Responds to Combination Therapy of First- and Third-Generation EGFR TKIs and Shifts Allelic Configuration at Resistance(2017)213 cited
- → The draft genome of the large yellow croaker reveals well-developed innate immunity(2014)204 cited
- → Circulating tumor DNA clearance predicts prognosis across treatment regimen in a large real-world longitudinally monitored advanced non-small cell lung cancer cohort(2020)117 cited
- → Clinical Utility of Cerebrospinal Fluid Cell-Free DNA as Liquid Biopsy for Leptomeningeal Metastases in ALK-Rearranged NSCLC(2019)112 cited
- → Erlotinib as Neoadjuvant Therapy in Stage IIIA (N2) EGFR Mutation-Positive Non-Small Cell Lung Cancer: A Prospective, Single-Arm, Phase II Study(2018)108 cited
- → Mutational profiling of poorly differentiated and anaplastic thyroid carcinoma by the use of targeted next‐generation sequencing(2019)89 cited
- → Comparative transcriptome analysis reveals that the extracellular matrix receptor interaction contributes to the venous metastases of hepatocellular carcinoma(2015)73 cited
- → Reduced Fetal Telomere Length in Gestational Diabetes(2014)72 cited
- → Clinical characteristics and prognostic value of the KRAS G12C mutation in Chinese non-small cell lung cancer patients(2020)71 cited